Welcome to our dedicated page for Vital Farms SEC filings (Ticker: VITL), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Vital Farms, Inc. filings document operating results, governance matters and material events for a public ethical food company built around pasture-raised eggs and related food products. Form 8-K reports furnish earnings releases, Regulation FD updates, product portfolio actions and exit or disposal activity tied to butter offerings.
Proxy and stockholder-meeting disclosures cover director elections, board structure, executive compensation advisory votes, governance policies and shareholder voting results. Other current reports document board appointments, board leadership transitions, committee service, indemnification arrangements and related corporate-governance matters for the Nasdaq-listed Delaware public benefit corporation.
Kennedy Kelly J. reported acquisition or exercise transactions in this Form 4 filing.
Vital Farms director Kelly J. Kennedy received an equity award of 10,436 restricted stock units (RSUs) for Common Stock. The award was granted at no cash cost as compensation and increases Kennedy’s direct holdings to 33,363 shares.
The RSUs will vest on the earlier of June 10, 2027 or the day before Vital Farms’ next annual stockholder meeting, as long as Kennedy remains in continuous service with the company through that date. This filing reflects a routine board-level equity grant rather than an open-market share purchase.
Amoo-Gottfried Kofi Owusu reported acquisition or exercise transactions in this Form 4 filing.
Vital Farms, Inc. director Kofi Owusu Amoo-Gottfried received a grant of 10,436 shares of common stock in the form of restricted stock units. These RSUs vest on the earlier of June 10, 2027 or the day before the next annual stockholder meeting, if he remains in continuous service. Following this award, he directly holds 41,497 shares of Vital Farms common stock. This transaction is a compensation-related equity grant, not an open-market purchase.
Ruiz Gisel reported acquisition or exercise transactions in this Form 4 filing.
Vital Farms director Gisel Ruiz received a new equity grant in the form of restricted stock units. The Form 4 reports an award of 10,436 shares of Common Stock at no cash cost, reflecting stock-based compensation rather than an open-market purchase.
The RSUs vest on the earlier of June 10, 2027 or the day before the company’s next annual meeting of stockholders, as long as Ruiz continues serving the company through that date. After this grant, Ruiz directly holds 56,985 shares, aligning her incentives more closely with other shareholders over the multiyear vesting period.
Post Denny Marie reported acquisition or exercise transactions in this Form 4 filing.
Vital Farms director Denny Marie Post received a grant of 10,436 shares of Common Stock in the form of restricted stock units. These RSUs were awarded at no cash price and increase her direct holdings to 29,748 shares following the transaction.
The RSUs will vest on the earlier of June 10, 2027, or the day before Vital Farms’ next annual meeting of stockholders, provided she continues to serve the company through the applicable vesting date. This is a compensation-related equity award, not an open-market stock purchase or sale.
Flanagan Glenda J reported acquisition or exercise transactions in this Form 4 filing.
Vital Farms, Inc. director Glenda J. Flanagan received a grant of 10,436 shares of common stock in the form of restricted stock units at no cash cost. These RSUs vest on the earlier of June 10, 2027 or the day before the company’s next annual meeting of stockholders, as long as she remains in continuous service.
After this compensation award, Flanagan holds a total of 47,934 shares of Vital Farms common stock directly, including the new RSU grant.
Vital Farms, Inc. director William B. Cyr reported an equity compensation grant. He acquired 10,436 shares of common stock in the form of restricted stock units at no cash cost, bringing his direct holdings to 24,230 shares after the award.
The RSUs will vest on the earlier of June 10, 2027 or the day before Vital Farms’ next annual meeting of stockholders, as long as Cyr continues to serve with the company through the applicable vesting date.
Khoury Karl reported acquisition or exercise transactions in this Form 4 filing.
Vital Farms, Inc. director Karl Khoury received an award of 10,436 restricted stock units (RSUs) of common stock on June 10, 2026. The grant carried no purchase price and increased his directly held equity position to 130,225 shares. The RSUs will vest on the earlier of June 10, 2027, or the day before Vital Farms’ next annual meeting of stockholders, as long as he remains in continuous service with the company through the applicable vesting date. This is a compensation-related equity grant rather than an open-market share purchase or sale.
Van Berkom & Associates Inc. filed an amendment to a Schedule 13G/A reporting beneficial ownership of 55,837 common shares of Vital Farms, Inc. The filing states this represents 0.13% of the class and that Van Berkom holds sole voting and dispositive power over those shares. The amendment is signed by Mathieu Sirois and dated 06/01/2026.
Vital Farms, Inc. Chief People Officer Reena Chauhan Van Hoven reported an open-market purchase of Common Stock. On May 19, 2026, she bought 2,242 shares at $8.92 per share. Following this transaction, she directly owns 25,827 shares, including 2,242 shares held jointly with her spouse.
Vital Farms, Inc. director Glenda J. Flanagan reported an open-market purchase of 6,100 shares of common stock. The shares were bought on May 18, 2026 at a weighted average price between $8.33 and $8.34 per share. Following this transaction, she directly holds 37,498 shares of Vital Farms common stock.